NYSE$OHI

Omega Healthcare Investors Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Reported strong results in the second quarter of 2020, with a focus on supporting tenants amidst the evolving pandemic.

Omega Healthcare Investors reported a net income of $102.0 million, or $0.43 per common share, and revenues of $256.4 million for the quarter ended June 30, 2020. The company completed $50 million in new investments and collected over 99% of contractual rent and mortgage payments.

  • Reported net income of $102.0 million or $0.43 per common share.
  • NAREIT Funds From Operations (FFO) was $186.5 million or $0.80 per common share.
  • Adjusted Funds From Operations (AFFO) was $189.8 million or $0.81 per common share.
  • Completed $50 million in new investments and invested $31 million in capital renovation and construction-in-progress projects.

Headline financials

Total Revenue

$256M

Previous: $225M+13.8%
EPS (adj)

$0.81

Previous: $0.77+5.2%
Capital Expenditures

-$122M

Previous: -$6.4M-1800.8%
Free Cash Flow

-$19.6M

Previous: $69.3M-128.3%
Net Income

$102M

Previous: $75.7M+34.7%
Operating Income

$157M

Previous: $127M+23.7%
Gross Profit

$255M

Previous: $217M+17.5%
Cash & Equivalents

$37M

Previous: $32.8M+13.0%
Total Assets

$9.69B

Previous: $9.1B+6.5%
Stock-Based Comp

$4.62M

Previous: $4.04M+14.4%

Revenue & EPS history

Omega Healthcare · Revenue · Quarterly

$256M

Q2 2020+13.8%vs Q2 2019
Beat estimate in 5 of 16 quarters(31%)
ActualEstimate

Revenue by segment

Omega Healthcare · $31.8M total across 3 segments · Q3 2023

  • Real estate loans interest income
    $24.9M
  • Non-real estate loans interest income
    $5.73M
  • Miscellaneous income
    $1.21M+398.8%

Forward guidance

Given the uncertainty related to the COVID-19 pandemic, its impact on the financial performance of the Company’s operators and the extent of future necessary government support to the operators, 2020 earnings guidance was previously withdrawn.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.1%

Avg return

Earnings day

+0.2%

Avg return

5 days after

+2.4%

Avg return

30 days after

49%

33 / 68 earnings

Positive

+13.1%

Q1 2022

Best reaction

-9.1%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.0%-2.6%-1.3%
Q4 2025+6.1%+5.8%+11.0%
Q3 2025+5.3%+7.9%+15.2%
Q1 2025-4.1%-7.5%-4.0%
Q4 2024-0.7%-6.0%-3.7%
Q3 2024+1.4%-4.5%-3.0%
Q2 2024+5.1%+1.8%+8.6%
Q1 2024+2.1%+0.8%+5.3%
Q4 2023+6.9%+10.2%+9.9%
Q3 2023-5.2%-5.8%-3.4%
Q2 2023-1.1%+1.0%+3.2%
Q1 2023+8.5%+7.9%+10.4%
Q4 2022-2.2%-5.1%-7.9%
Q3 2022-1.3%+2.5%-5.1%
Q2 2022+1.8%+3.2%+5.4%
Q1 2022+13.1%+11.3%+15.9%
Q4 2021-8.4%-11.2%-8.7%
Q3 2021+0.2%-4.7%-7.6%
Q2 2021-4.6%-3.2%-6.9%
Q1 2021-2.0%-3.9%-0.1%
Q4 2020-0.6%-1.2%+1.2%
Q3 2020-1.1%+3.8%+23.1%
Q2 2020+3.0%+4.8%-0.2%
Q1 2020+0.0%+1.8%+21.9%
Q4 2019-0.0%+1.4%-7.7%
Q3 2019-2.2%-5.4%-2.6%
Q2 2019+1.5%+7.8%+15.4%
Q1 2019+1.5%+4.3%+2.3%
Q4 2018-5.9%-6.9%-6.5%
Q3 2018+5.2%+7.5%+15.6%
Q2 2018+3.7%+5.5%+10.9%
Q1 2018+3.4%+7.0%+13.1%
Q4 2017-2.9%+1.4%+3.7%
Q3 2017-9.1%-10.6%-15.6%
Q2 2017-3.4%-4.9%-5.8%
Q1 2017-2.6%-0.8%-3.3%
Q4 2016-5.0%-1.8%-3.7%
Q3 2016-1.7%-6.5%-5.8%
Q2 2016+1.5%+1.9%+3.5%
Q1 2016-1.2%
Q4 2015+4.4%
Q3 2015-0.5%
Q2 2015+1.2%
Q1 2015-3.5%
Q4 2014-0.7%
Q3 2014+1.8%
Q2 2014+0.1%
Q1 2014-0.6%
Q4 2013-1.4%
Q3 2013-2.0%
Q2 2013-7.3%
Q1 2013+0.5%
Q4 2012+4.2%
Q3 2012-3.0%
Q2 2012+1.1%
Q1 2012+0.4%
Q4 2011-1.8%
Q3 2011+2.2%
Q2 2011+3.2%
Q1 2010+0.1%
Q1 2011+1.3%
Q4 2008-2.2%
Q4 2010-2.2%
Q3 2010-4.4%
Q3 2009-4.4%
Q2 2009+1.3%
Q2 2010+1.3%
Q4 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro